BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35806091)

  • 21. Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism.
    Sudhaman S; Prasad K; Behari M; Muthane UB; Juyal RC; Thelma BK
    J Med Genet; 2016 Jul; 53(7):450-6. PubMed ID: 26864383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis.
    Aghdassi AA; John DS; Sendler M; Weiss FU; Reinheckel T; Mayerle J; Lerch MM
    J Biol Chem; 2018 Jan; 293(3):1018-1029. PubMed ID: 29229780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin B overexpression induces degradation of perilipin 1 to cause lipid metabolism dysfunction in adipocytes.
    Mizunoe Y; Kobayashi M; Hoshino S; Tagawa R; Itagawa R; Hoshino A; Okita N; Sudo Y; Nakagawa Y; Shimano H; Higami Y
    Sci Rep; 2020 Jan; 10(1):634. PubMed ID: 31959889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic status of lysosomal cathepsin in bovine oocytes and preimplantation embryos.
    Li J; Maeji M; Balboula AZ; Aboelenain M; Fujii T; Moriyasu S; Bai H; Kawahara M; Takahashi M
    J Reprod Dev; 2020 Feb; 66(1):9-17. PubMed ID: 31685761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GCH1 variants contribute to the risk and earlier age-at-onset of Parkinson's disease: a two-cohort case-control study.
    Pan HX; Zhao YW; Mei JP; Fang ZH; Wang Y; Zhou X; Zhou YJ; Zhang R; Zhang KL; Jiang L; Zeng Q; He Y; Wang Z; Liu ZH; Xu Q; Sun QY; Yang Y; Hu YC; Chen YS; Du J; Lei LF; Zhang HN; Wang CY; Yan XX; Shen L; Jiang H; Tan JQ; Li JC; Tang BS; Guo JF
    Transl Neurodegener; 2020 Aug; 9(1):31. PubMed ID: 32746945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cathepsin B SNPs elevate the pathological development of oral cancer and raise the susceptibility to carcinogen-mediated oral cancer.
    Chen MK; Su SC; Lin CW; Tsai CM; Yang SF; Weng CJ
    Hum Genet; 2012 Dec; 131(12):1861-8. PubMed ID: 22851129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rare variants in PLXNA4 and Parkinson's disease.
    Schulte EC; Stahl I; Czamara D; Ellwanger DC; Eck S; Graf E; Mollenhauer B; Zimprich A; Lichtner P; Haubenberger D; Pirker W; Brücke T; Bereznai B; Molnar MJ; Peters A; Gieger C; Müller-Myhsok B; Trenkwalder C; Winkelmann J
    PLoS One; 2013; 8(11):e79145. PubMed ID: 24244438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of TMEM230 mutations in patients with familial and sporadic Parkinson's disease in a Taiwanese population.
    Fan TS; Lin CH; Lin HI; Chen ML; Wu RM
    Am J Med Genet B Neuropsychiatr Genet; 2017 Oct; 174(7):751-756. PubMed ID: 28766910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cathepsin B overexpression due to acid sphingomyelinase ablation promotes liver fibrosis in Niemann-Pick disease.
    Moles A; Tarrats N; Fernández-Checa JC; Marí M
    J Biol Chem; 2012 Jan; 287(2):1178-88. PubMed ID: 22102288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of cysteine proteases cathepsin B and cathepsin L in pancreatic adenocarcinoma.
    Niedergethmann M; Wostbrock B; Sturm JW; Willeke F; Post S; Hildenbrand R
    Pancreas; 2004 Oct; 29(3):204-11. PubMed ID: 15367886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
    Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
    Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsin B Activity Initiates Apoptosis via Digestive Protease Activation in Pancreatic Acinar Cells and Experimental Pancreatitis.
    Sendler M; Maertin S; John D; Persike M; Weiss FU; Krüger B; Wartmann T; Wagh P; Halangk W; Schaschke N; Mayerle J; Lerch MM
    J Biol Chem; 2016 Jul; 291(28):14717-31. PubMed ID: 27226576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cathepsin B Regulates Mice Granulosa Cells' Apoptosis and Proliferation In Vitro.
    Chen C; Ahmad MJ; Ye T; Du C; Zhang X; Liang A; Yang L
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C-terminal α-synuclein truncations are linked to cysteine cathepsin activity in Parkinson's disease.
    McGlinchey RP; Lacy SM; Huffer KE; Tayebi N; Sidransky E; Lee JC
    J Biol Chem; 2019 Jun; 294(25):9973-9984. PubMed ID: 31092553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families.
    Ngcungcu T; Oti M; Sitek JC; Haukanes BI; Linghu B; Bruccoleri R; Stokowy T; Oakeley EJ; Yang F; Zhu J; Sultan M; Schalkwijk J; van Vlijmen-Willems IMJJ; von der Lippe C; Brunner HG; Ersland KM; Grayson W; Buechmann-Moller S; Sundnes O; Nirmala N; Morgan TM; van Bokhoven H; Steen VM; Hull PR; Szustakowski J; Staedtler F; Zhou H; Fiskerstrand T; Ramsay M
    Am J Hum Genet; 2017 May; 100(5):737-750. PubMed ID: 28457472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational Design of a Humanized Antibody Inhibitor of Cathepsin B.
    Dai Z; Cheng Q; Zhang Y
    Biochemistry; 2020 Apr; 59(14):1420-1427. PubMed ID: 32212642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice.
    Sevenich L; Werner F; Gajda M; Schurigt U; Sieber C; Müller S; Follo M; Peters C; Reinheckel T
    Oncogene; 2011 Jan; 30(1):54-64. PubMed ID: 20818432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.
    Pal P; Sadhukhan T; Chakraborty S; Sadhukhan S; Biswas A; Das SK; Ray K; Ray J
    Neuromolecular Med; 2019 Sep; 21(3):287-294. PubMed ID: 31134487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.